NCT05096494 - Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions

Moderate to Severe Acute Lower Back Pain

Interventions

DRUG

SP-103

SP-103 topical system is worn daily for 12 hours per day for 28 days

DRUG

Placebo

Placebo topical system is worn daily for 12 hours per day, for 28 days

Trial Locations (10)

Scilex Research Site 08, Charleston

Horizon Clinical Research, Newnan

Costal Clinical Research Specialists, Fernandina Beach

Costal Clinical Research Specialists, Jacksonville

Western Reserve Hospital, Cuyahoga Falls

Chicago Anaesthesia Research Specialists, Chicago

Neuroscience Research Center, Overland Park

Injury Care Research, Boise

Arizona Research Center, Phoenix

Neuroscience Institute, Overlook Medical Center, Summit